Live Quote · NASDAQHUMAHealthcare· Biotechnology

Humacyte, Inc.

$0.45▼ 17.90%($-0.10)
MKT CAP $123.73MNEXT EARNINGS Mar 26, 2027
50%
Bullish
TickerSpark Score
46/100
▌ Weak
50
Valuation
20
Profitability
60
Growth
68
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HUMA research report →

Analyst Price Target
$1.33+198.6% vs. today

Range $1 – $2

Analyst RatingBuy
9 Buy2 Hold0 Sell

Price Chart

-60.23% · this period
$1.49$0.92$0.35Nov 20May 26Nov 20
52-Week Range9% of range
Low
$0.34
Current
$0.45
High
$1.53